Myelofibrosis Clinical Trials

According to the Leukemia & Lymphoma Society, Myelofibrosis is a type of Myeloproliferative Neoplasm that develops when the bone marrow produces a surplus of blood cells and scar tissue begins to form in the bone marrow. Myelofibrosis is a rare chronic disorder that is most common for people over the age of 50 and it only affects 1.5 out of every 100,000 people in the U.S. annually. There are several active clinical trials available around the U.S. that specialize in Myelofibrosis.

Massive Bio’s number one priority is to create positive outcomes for cancer patients. With the Clinical Trial Matching Service and Virtual Tumor Board, you are one-step closer to reaching that positive outcome.

Cancer clinical trials are important for cancer treatment; they find and prove new ways to fight cancer. By participating in a clinical trial, you can find the best treatment for your Myelofibrosis Neoplasms and help others who are struggling with Myelofibrosis. Getting access to the right clinical trials and right treatments shouldn’t have to be overwhelming. That’s why Massive Bio uses the clinical trial matching service to match Myelofibrosis patients to the right clinical trials based on the stage of disease, biomarker status, geographical location and past medical history.

There are approximately 400 myelofibrosis clinical trials across the United States available for eligible patients to enroll in. The latest drugs and therapies in cancer research are evaluated and compared to standard treatments. Participation in clinical trials helps further research and provides future patients access to new treatments. For rare diseases like myelofibrosis, there are a lack of new treatment options so clinical trials are important for the development of new drugs. Contact Massive Bio for assistance in finding and enrolling into a clinical trial.

Discomforting Symptoms

Symptoms that can occur from myelofibrosis include anemia, skin planes, enlarging of the spleen and liver, portal hypertension, dilated veins in the stomach and esophagus, night sweats, blood clots, infections, fever, itching, bruising and bleeding, bone or joint pain, weight loss and extra medullary hematopoiesis.

Treatment Side Effects

Side effects from treatment can sometimes involve increase in platelets, which could lead to blood clots and worsening of anemia. Other possible side effects also include bruising, dizziness and headaches.

Possible Risk Factors

Some risk factors that may contribute to the increased potential of developing Myelofibrosis involve being exposed to ionizing radiation or petrochemicals such as benzene or toluene. Having a mutation in the JAK2 gene is also a contributing risk factor.

Benefits

Find Myelofibrosis Clinical Trials

No Needed Travel Until Enrollment

The clinical trial matching process is all virtual, which means there is no need to travel until you are completely enrolled into a clinical trial. Receive your clinical trial match results virtually, and speak with a patient advocate over the phone about eligibility and enrollment.

Pre-screening for Myelofibrosis Clinical Trials

Our patient advocates receive your medical records and closely review your specific case to provide the best trial matches for your disease stage, biomarker status, geographical location and more. Our number one priority is to provide you with a positive outcome.

Find Your Best Option

Our SYNERGY-AI technology platform sorts through over 30,000+ of actively recruiting clinical trials to provide you with the most personalized matches possible for your specific case.

Full Guidance

A patient advocate will guide you through trial matching, qualifying, and enrolling. Any questions or concerns you may have can be brought to your advocate to ensure you are confident in the process and are choosing the best option for your case.